For the Inventor, By the Inventor

Enter assignee name

Somerset, NJ, United States of America

Apicore US LLC

Calculating rank

USPTO Granted Patents = 16

% Expired Patents = 18.8

Trademarks = 1

Forward Citations = 15

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Ravishanker Kovi (16 out of 31 patents)

Jayaraman Rao Kannapan (9 out of 13 patents)

Satyam Nampalli (7 out of 16 patents)

4. Peter Xavier Tharial (7 out of 9 patents)

5. Ashish Naik (4 out of 5 patents)

6. Sanjay F Thakor (4 out of 5 patents)

7. Piyush D Fadadu (3 out of 3 patents)

8. Ananda Babu Thirunavakarasu (3 out of 5 patents)

9. Veerabhadra Rao Bobbili (3 out of 4 patents)

10. Gaurav Yadav (2 out of 2 patents)

11. Shivnath Sahebrao Patil (2 out of 4 patents)

12. Rajesh A Patel (1 out of 3 patents)

13. Talluri Bhushaiah Chowdary (1 out of 2 patents)

14. Anand Vijaykumar Mantri (1 out of 2 patents)

15. Gaurav Kulkarni (1 out of 2 patents)

16 patents: Sort by Forward Citations

1. 11034714 - Process of making regadenoson and novel polymorphs thereof (2021-06-15),

2. 10752580 - Process for preparation of isosulfan blue (2020-08-25),

3. 10626086 - Process for the preparation of isosulfan blue (2020-04-21),

4. 10590071 - Process for the preparation of isosulfan blue (2020-03-17),

5. 10519121 - Process and novel polymorphic form of vortioxetine and its pharmaceutically acceptable salts (2019-12-31),

6. 10508080 - Process for the preparation of isosulfan blue (2019-12-17),

7. 10464888 - Process for the preparation of isosulfan blue (2019-11-05),

8. 10442832 - Process of making regadenoson and novel polymorph thereof (2019-10-15),

9. 10392417 - Polymorph of regadenoson and process for preparation thereof (2019-08-27),

10. 10221184 - Polymorphs of ponatinib hydrochloride (2019-03-05),

11. 9988389 - Processes for making ponatinib and intermediates thereof (2018-06-05),

12. 9822145 - Methods of making carfilzomib and intermediates thereof (2017-11-21),

13. 9493473 - Processes for making ponatinib and intermediates thereof (2016-11-15),

14. 9353050 - Process for preparation of isosulfan blue (2016-05-31),

15. 9150511 - Process for preparing saxagliptin and its novel intermediates useful in the synthesis thereof (2015-10-06),

Company Overview

Apicore US LLC is a biotechnology firm based in Somerset, NJ, specializing in the development and manufacturing of advanced pharmaceutical products. The company focuses on innovative solutions in drug formulation and delivery, particularly in the fields of oncology and infectious diseases. With a commitment to enhancing therapeutic efficacy, Apicore leverages cutting-edge research and technology to address complex medical challenges, aiming to improve patient outcomes through its specialized offerings.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

16 Patents

#14 in

#19,944 in

#37,887 in the World

Somerset, NJ, United States of America

Apicore US LLC

Forward Citations = 15

24 inventors:

Ravishanker Kovi (16 out of 31 patents)

Jayaraman Rao Kannapan (9 out of 13 patents)

Satyam Nampalli (7 out of 16 patents)

4. Peter Xavier Tharial (7 out of 9 patents)

5. Ashish Naik (4 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Apicore US LLC. Retrieved from https://idiyas.com/company/apicore-us

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…